Index of reports
> Cases with Anaemia (102)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vincristine where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 102 Next >>
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male
Reactions: Rectal Haemorrhage, Constipation, Cardiac Disorder, Hospitalisation, Granulocytopenia, Inappropriate Antidiuretic Hormone Secretion, Thrombocytopenia, Cardiac Failure Congestive, Pneumonia, Anaemia, Pancytopenia, Atrial Fibrillation, Febrile Neutropenia, Syncope, Embolism, Sepsis, Dehydration, Asthenia, Mantle Cell Lymphoma Recurrent, Leukopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Mantle Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Mantle Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Mantle Cell Lymphoma
Possible Vincristine side effects in
Reported by a physician from United Kingdom on 2012-08-10
Patient:
Reactions: Diarrhoea, Anaemia, Dizziness, Pulmonary Mycosis, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Prednisolone
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-08
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Velcade
Dosage: 2.6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Other drugs received by patient: Prednisolone; Tramadol HCL; Chlorhexidine Gluconate; Omeprazole; Itraconazole; Acyclovir; Symbicort; Montelukast; Cetraben / 01561901 /; Fluconazole; Nitrofurantoin; Citalopram Hydrobromide; NEO-Mercazole TAB; Cotrim; Ferrous Fumarate; Ventolin; Enoxaparin Sodium; Metoclopramide
Possible Vincristine side effects in male
Reported by a lawyer from United States on 2012-08-03
Patient: male
Reactions: Tinnitus, Femur Fracture, Osteomyelitis, Oral Cavity Fistula, Erythema, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Oedema Peripheral, Carpal Tunnel Syndrome, Radiculopathy, Intervertebral Disc Protrusion, Cellulitis, Gingival Bleeding, Pneumonia, Pain in Extremity, Anaemia, Encephalopathy, Otitis Externa, Nasal Septum Deviation, Abscess JAW, Paraesthesia, Osteosclerosis, Rhinitis Allergic, Osteonecrosis, Mental Disorder, Osteoporosis, Pain, Multiple Myeloma, Periodontitis, Overdose, Neuropathy Peripheral, Intervertebral Disc Degeneration, Depression, Injury, Gastrooesophageal Reflux Disease, Pain in JAW, Dyspnoea, Spondylolysis, Spondylolisthesis, Hepatitis Acute, Musculoskeletal Pain, Febrile Neutropenia, Osteolysis, Cognitive Disorder, Deformity, Amnesia, Osteoarthritis, Anxiety, Osteonecrosis of JAW, Heart Rate Increased, Infection
Drug(s) suspected as cause:
Aredia
Thalidomide
Dosage: 50 mg, qd
Vincristine
Zometa
Dosage: 4 mg, qmo
Other drugs received by patient: Clonazepam; Dexamethasone; Oxycontin; Tegretol; Neurontin
Possible Vincristine side effects in female
Reported by a physician from Poland on 2012-08-02
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Retroperitoneal Mass, Vomiting, Nausea, Anaemia, Nephropathy Toxic, Folate Deficiency, Iron Deficiency, Herpes Zoster, Vitamin B12 Increased, Asthenia, Beta 2 Microglobulin Increased, Leukopenia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Doxorubicin Hydrochloride
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Prednisone
Administration route: Oral
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Vincristine
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Other drugs received by patient: Heviran; Tamoxifen Citrate
Possible Vincristine side effects in
Reported by a physician from Italy on 2012-07-27
Patient:
Reactions: Anaemia, Skin Toxicity, Febrile Neutropenia, Mucosal Inflammation, Neurotoxicity, Respiratory Failure, Sepsis, Neutropenia, Cardiotoxicity, Septic Shock, Thrombocytopenia, Myocardial Infarction, Diffuse Large B-Cell Lymphoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Epirubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Prednisone and Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Vincristine side effects in female
Reported by a physician from United Kingdom on 2012-07-27
Patient: female, weighing 53.0 kg (116.6 pounds)
Reactions: Anaemia, Neutropenia, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Furosemide
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-07-27
Patient: male
Reactions: Tinnitus, Femur Fracture, Oral Cavity Fistula, Osteomyelitis, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Carpal Tunnel Syndrome, Radiculopathy, Intervertebral Disc Protrusion, Cellulitis, Gingival Bleeding, Pneumonia, Anaemia, Encephalopathy, Otitis Externa, Abscess JAW, Nasal Septum Deviation, Paraesthesia, Rhinitis Allergic, Osteosclerosis, Osteonecrosis, Mental Disorder, Osteoporosis, Pain, Multiple Myeloma, Periodontitis, Neuropathy Peripheral, Overdose, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pain in JAW, Spondylolysis, Hepatitis Acute, Spondylolisthesis, Febrile Neutropenia, Osteolysis, Cognitive Disorder, Amnesia, Deformity, Osteoarthritis, Anxiety, Osteonecrosis of JAW, Infection
Drug(s) suspected as cause:
Aredia
Thalidomide
Dosage: 50 mg, qd
Vincristine
Zometa
Dosage: 4 mg, qmo
Other drugs received by patient: Clonazepam; Neurontin; Oxycontin; Tegretol; Dexamethasone
Possible Vincristine side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-23
Patient: female, weighing 67.0 kg (147.4 pounds)
Reactions: Small Intestinal Obstruction, Anaemia, Febrile Neutropenia, Device Related Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-04-26
Doxorubicin HCL
Start date: 2012-04-26
Prednisolone
Administration route: Oral
Start date: 2012-04-26
Vincristine
Start date: 2012-04-26
Possible Vincristine side effects in
Reported by a physician from Italy on 2012-07-20
Patient:
Reactions: Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma Recurrent, Mucosal Inflammation, Neurotoxicity, Sepsis, Adverse Event, Cardiotoxicity, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Lymphoma, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750 mg/m2 on day 1 for chop and 750 mg/m2 on day 2 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: 50 mg/m2 on day 1 for chop and 50 mg/m2 on day 2 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 100 mg on days 1-5 for chop and r-chop
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: 375 mg/m2 on day 1 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: 1.4 mg/m2 on day 1 for chop and 1.4 mg/m2 on day 2 for r-chop upto a maximum dose of 2 mg
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Vincristine side effects in male
Reported by a lawyer from United States on 2012-07-20
Patient: male
Reactions: Femur Fracture, Tinnitus, Osteomyelitis, Oral Cavity Fistula, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Intervertebral Disc Protrusion, Cellulitis, Pneumonia, Anaemia, Otitis Externa, Abscess JAW, Nasal Septum Deviation, Paraesthesia, Osteonecrosis, Rhinitis Allergic, Mental Disorder, Pain, Multiple Myeloma, Periodontitis, Overdose, Neuropathy Peripheral, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pain in JAW, Spondylolysis, Spondylolisthesis, Hepatitis Acute, Febrile Neutropenia, Osteolysis, Deformity, Amnesia, Osteoarthritis, Osteonecrosis of JAW, Infection
Drug(s) suspected as cause:
Aredia
Thalidomide
Dosage: 50 mg, qd
Vincristine
Zometa
Dosage: 4 mg, qmo
Other drugs received by patient: Neurontin; Clonazepam; Oxycontin; Dexamethasone; Tegretol
Possible Vincristine side effects in male
Reported by a consumer/non-health professional from Germany on 2012-07-09
Patient: male
Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-04-06
End date: 2012-04-06
Prednisolone
Dosage: 500 mg, qd
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-06
Rituximab
Dosage: 750 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-02
Vincristine
Dosage: 2 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Other drugs received by patient: Novalgin / 00169801 /; Morphine Sulfate; Pantoprazole; Dipyrone TAB; Metoclopramide; Acyclovir
Possible Vincristine side effects in female
Reported by a consumer/non-health professional from Germany on 2012-07-06
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, bid
Start date: 2009-07-23
Campath
Dosage: 20 mg, qd
Start date: 2009-07-07
Campath
Dosage: 30 mg, qd
Start date: 2009-08-06
End date: 2009-08-06
Campath
Dosage: 30 mg, qd
Start date: 2009-09-11
End date: 2009-10-22
Campath
Dosage: 10 mg, qd
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-08-20
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-21
Cyclophosphamide
Dosage: 1250 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-09-08
End date: 2009-09-08
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-07
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-07
Doxorubicin HCL
Dosage: 80 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-21
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-09-08
End date: 2009-09-08
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-23
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-08-20
Filgrastim
Dosage: 3000 iu, unk
Start date: 2009-07-26
End date: 2009-08-27
Filgrastim
Dosage: unk on days 4 through 13 of course 5
Start date: 2009-08-20
Filgrastim
Dosage: unk on days 4 through 12 of course 6
Start date: 2009-09-08
Filgrastim
Dosage: unk on days 4, 5, 6 of course 1
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Filgrastim
Dosage: unk on days 4 through 15 of course 2
Start date: 2009-07-07
Filgrastim
Dosage: unk on days 4 through 8 and day 13 of course 3
Start date: 2009-07-23
Filgrastim
Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
Start date: 2009-08-06
Filgrastim
Dosage: 30000 iu, qd
Start date: 2009-09-11
End date: 2009-09-19
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-06-23
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-09-11
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-07-07
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-15
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-08-06
End date: 2009-08-10
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-07-23
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2009-09-08
End date: 2009-09-08
Vincristine
Dosage: 2 mg, once
Start date: 2009-06-23
Vincristine
Dosage: 1 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-15
Vincristine
Dosage: 2 mg, once
Start date: 2009-08-20
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-23
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-07
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-21
Vincristine
Vincristine
Dosage: 2 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva
Possible Vincristine side effects in 65 year old female
Reported by a physician from Netherlands on 2012-07-06
Patient: 65 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1310 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Doxorubicin HCL
Dosage: 88 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Neulasta
Dosage: 6 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-26
Rituximab
Dosage: 660 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Vincristine
Dosage: 2 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Possible Vincristine side effects in
Reported by a physician from South Africa on 2012-07-05
Patient:
Reactions: Pneumonia, Hepatotoxicity, Anaemia, Tuberculosis, Hyponatraemia, Kaposi's Sarcoma, Thrombocytopenia, Generalised Oedema
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 10 u/m2
Indication: Kaposi's Sarcoma AIDS Related
Doxorubicin HCL
Indication: Kaposi's Sarcoma AIDS Related
Etoposide
Dosage: 50-100 mg for 1-21 days of a 28 day cycle.
Administration route: Oral
Indication: Kaposi's Sarcoma AIDS Related
Lamivudine Stavudine Nevirapine
Indication: Kaposi's Sarcoma AIDS Related
Vincristine
Dosage: capped at 2 mg
Indication: Kaposi's Sarcoma AIDS Related
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-07-03
Patient: male
Reactions: Femur Fracture, Tinnitus, Osteomyelitis, Oral Cavity Fistula, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Pneumonia, Cellulitis, Anaemia, Otitis Externa, Nasal Septum Deviation, Paraesthesia, Osteonecrosis, Rhinitis Allergic, Mental Disorder, Pain, Multiple Myeloma, Periodontitis, Overdose, Neuropathy Peripheral, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pain in JAW, Spondylolisthesis, Hepatitis Acute, Febrile Neutropenia, Osteolysis, Deformity, Amnesia, Osteoarthritis, Osteonecrosis of JAW, Infection
Drug(s) suspected as cause:
Aredia
Thalidomide
Dosage: 50 mg, qd
Vincristine
Zometa
Dosage: 4 mg, qmo
Other drugs received by patient: Dexamethasone; Tegretol; Oxycontin; Clonazepam; Neurontin
Possible Vincristine side effects in 69 year old male
Reported by a individual with unspecified qualification from Germany on 2012-07-03
Patient: 69 year old male
Reactions: Anaemia, Febrile Neutropenia, Asthenia, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Mabthera
Indication: non-Hodgkin's Lymphoma
Prednisone
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Possible Vincristine side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient: 67 year old male
Reactions: Weight Decreased, Anaemia, Acute Phosphate Nephropathy, Mental Status Changes, Hypercalcaemia, Hyperuricaemia, Haemodialysis, Tumour Lysis Syndrome, Renal Impairment, Oliguria, Leukocytosis, Thrombocytopenia, Decreased Appetite, Renal Failure Acute, Hepatosplenomegaly
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Chemotherapy
Dexamethasone Sodium Phosphate
Indication: Chemotherapy
Doxorubicin HCL
Indication: Chemotherapy
Vincristine
Indication: Chemotherapy
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Tinnitus, Femur Fracture, Oral Cavity Fistula, Osteomyelitis, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Cellulitis, Pneumonia, Anaemia, Otitis Externa, Nasal Septum Deviation, Paraesthesia, Osteonecrosis, Rhinitis Allergic, Mental Disorder, Pain, Multiple Myeloma, Overdose, Neuropathy Peripheral, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pain in JAW, Spondylolisthesis, Hepatitis Acute, Febrile Neutropenia, Osteolysis, Amnesia, Deformity, Osteoarthritis, Osteonecrosis of JAW, Infection
Drug(s) suspected as cause:
Aredia
Thalidomide
Dosage: 50 mg, qd
Vincristine
Zometa
Dosage: 4 mg, qmo
Other drugs received by patient: Tegretol; Clonazepam; Neurontin; Oxycontin; Dexamethasone
Possible Vincristine side effects in
Reported by a individual with unspecified qualification from Korea, Republic of on 2012-06-26
Patient:
Reactions: Abdominal Pain, Hyperbilirubinaemia, Anaemia, Alanine Aminotransferase Increased, Febrile Neutropenia, Rash, Pyrexia, Peripheral Sensory Neuropathy, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Asthenia, Thrombocytopenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: given on day 1 of each cycle
Indication: B-Cell Lymphoma
Mabthera
Dosage: on day 1 of every cycle
Indication: B-Cell Lymphoma
Prednisolone
Dosage: given on days 1 to 5 of every cycle (repeated every 3 weeks)
Administration route: Oral
Indication: B-Cell Lymphoma
Vincristine
Dosage: given on day 1 of every cycle; dose: 1.4 mg/m2 ( maximum 2.0 mg)
Indication: B-Cell Lymphoma
Possible Vincristine side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-18
Patient: male
Reactions: Tinnitus, Femur Fracture, Pain, Oral Cavity Fistula, Osteomyelitis, Multiple Myeloma, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Neuropathy Peripheral, Overdose, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pneumonia, Cellulitis, Hepatitis Acute, Spondylolisthesis, Anaemia, Febrile Neutropenia, Otitis Externa, Osteolysis, Deformity, Nasal Septum Deviation, Paraesthesia, Osteoarthritis, Osteonecrosis, Rhinitis Allergic, Osteonecrosis of JAW, Mental Disorder, Infection
Drug(s) suspected as cause:
Aredia
Thalidomide
Dosage: 50 mg, qd
Vincristine
Zometa
Dosage: 4 mg, qmo
Other drugs received by patient: Clonazepam; Oxycontin; Neurontin; Dexamethasone; Tegretol
Possible Vincristine side effects in male
Reported by a physician from Italy on 2012-06-14
Patient: male
Reactions: Epstein-Barr Virus Infection, Anaemia, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Disease Progression, Infection
Drug(s) suspected as cause:
Carboplatin
Indication: Burkitt's Lymphoma
Carmustine
Indication: Burkitt's Lymphoma
Cisplatin
Indication: Burkitt's Lymphoma
Cyclophosphamide
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Granulocyte Colony Stimulating Factor
Indication: Burkitt's Lymphoma
Ifosfamide
Indication: Burkitt's Lymphoma
Melphalan Hydrochloride
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Burkitt's Lymphoma
Radiotherapy
Indication: Burkitt's Lymphoma
Rituximab
Indication: Burkitt's Lymphoma
Unknown Medication
Dosage: antimicrobial prophylaxis
Indication: Burkitt's Lymphoma
Vincristine
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication
Possible Vincristine side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-11
Patient:
Reactions: Nausea, Bacteraemia, Anaemia, Hypoalbuminaemia, Abscess, Neutropenia, Thrombocytopenia, Decreased Appetite
Drug(s) suspected as cause:
Azacitidine
Azacitidine
Indication: Lymphoma
Cyclophosphamide
Dosage: for 6 to 9 days
Indication: Lymphoma
Mabthera
Dosage: for 8 days
Indication: Lymphoma
Vincristine
Dosage: for 8 days
Indication: Lymphoma
Possible Vincristine side effects in 17 year old female
Reported by a physician from United States on 2012-06-08
Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)
Reactions: Blood Bilirubin Increased, Pyrexia, Caecitis, Loss of Consciousness, Oedema Peripheral, Pulmonary Oedema, Hypocalcaemia, Acute Respiratory Distress Syndrome, Melaena, Hypertriglyceridaemia, Epistaxis, Dysphagia, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Eating Disorder, Tremor, Cerebral Infarction, Depressed Level of Consciousness, Neutropenia, Confusional State, Dyskinesia, Somnolence, Splenic Infarction, Hypokalaemia, Pleural Effusion, White Blood Cell Count Decreased, Cerebrovascular Accident, Ascites, Diarrhoea, Hypophagia, Hypoalbuminaemia, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Dalteparin Sodium
Indication: Product Used FOR Unknown Indication
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-04-13
Oncaspar
Indication: T-Cell Type Acute Leukaemia
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Other drugs received by patient: Nystatin; Lansoprazole; Insulin Aspart; Piperacillin and Tazobactam; Vancomycin; Voriconazole
Possible Vincristine side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-07
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Pneumonia, Anaemia, Febrile Neutropenia, Gastritis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-01-19
Doxorubicin HCL
Start date: 2012-01-19
Prednisone TAB
Administration route: Oral
Start date: 2012-01-18
Vincristine
Start date: 2012-01-19
Possible Vincristine side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-06
Patient: female, weighing 67.0 kg (147.4 pounds)
Reactions: Anaemia, Febrile Neutropenia, Device Related Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-04-26
Doxorubicin HCL
Start date: 2012-04-26
Prednisolone
Administration route: Oral
Start date: 2012-04-26
Vincristine
Start date: 2012-04-26
Possible Vincristine side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05
Patient: male, weighing 102.6 kg (225.7 pounds)
Reactions: Cardio-Respiratory Arrest, Respiratory Failure, Anaemia, Troponin I Increased, Thrombocytopenia, Infection
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 101 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-07-05
End date: 2011-07-05
Cyclophosphamide
Dosage: 603 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-07-02
End date: 2011-07-04
Cytarabine
Dosage: 6 g, cyclic
Indication: Mantle Cell Lymphoma
End date: 2011-07-30
Dexamethasone
Dosage: 40 mg, cyclic
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: 20 unk, unk
Administration route: Oral
End date: 2011-07-15
Methotrexate
Dosage: 1600 mg, cyclic
End date: 2011-07-28
Methotrexate
Dosage: 400 mg, cyclic
Indication: Mantle Cell Lymphoma
End date: 2011-07-27
Rituximab
Dosage: 750 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-07-01
End date: 2011-07-26
Velcade
Dosage: 2.6 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-07-01
End date: 2011-07-26
Vincristine
Dosage: 2 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-07-05
End date: 2011-07-12
Other drugs received by patient: Filgrastim; Ferrous Sulfate TAB; Heparin; Senokot; Triamcinolone Acetonide; Compazine; Ciprofloxacin; Fluconazole; Omeprazole; Mesna; Prevident; Valtrex; Vitamin C / 00008001 /; Methylprednisolone; Periogard; Ultram; Vitamin D
Possible Vincristine side effects in
Reported by a physician from Germany on 2012-06-01
Patient:
Reactions: Respiratory Disorder, Pain, Myelodysplastic Syndrome, Pyrexia, Neoplasm, Death, Completed Suicide, Thrombocytopenia, Vomiting, Nausea, Anaemia, Acute Myeloid Leukaemia, Toxicity To Various Agents, Haematotoxicity, Hodgkin's Disease, Mucosal Inflammation, Accident, Alopecia, Gastrointestinal Disorder, Nervous System Disorder, non-Hodgkin's Lymphoma, Cardiovascular Disorder, Leukopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Cyclophosphamide
Indication: Hodgkin's Disease
Doxorubicin HCL
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Prednisone TAB
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Vincristine side effects in 77 year old male
Reported by a physician from Denmark on 2012-05-29
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Other drugs received by patient: Pinex; Sulphamethizole; Valacyclovir Hydrochloride; Omeprazole
Possible Vincristine side effects in 18 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-28
Patient: 18 year old female
Reactions: Oligohydramnios, Normal Newborn, Anaemia, Febrile Neutropenia, Neutropenia, Pregnancy, Thrombocytopenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1 df: 2.2g/m2
Indication: Rhabdomyosarcoma
Dactinomycin
Dosage: q21d
Indication: Rhabdomyosarcoma
Mesna
Indication: Rhabdomyosarcoma
Neupogen
Indication: Rhabdomyosarcoma
Vincristine
Indication: Rhabdomyosarcoma
Possible Vincristine side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-28
Patient: female
Reactions: Foetal Growth Restriction, Premature Baby, Anaemia, Thrombocytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Doxorubicin HCL
Ifosfamide
Dosage: 1df= 9g/m3 over 5 days.
Indication: Ewing's Sarcoma
Vincristine
Page 1 Next >>
|